APA (7th ed.) Citation

Ippen, F. M. (2019). The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 achieves antitumor activity in PIK3CA-Mutant breast cancer brain metastases. Clinical cancer research, 25(11), . https://doi.org/10.1158/1078-0432.CCR-18-3049

Chicago Style (17th ed.) Citation

Ippen, Franziska M. "The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA-Mutant Breast Cancer Brain Metastases." Clinical Cancer Research 25, no. 11 (2019). https://doi.org/10.1158/1078-0432.CCR-18-3049.

MLA (9th ed.) Citation

Ippen, Franziska M. "The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA-Mutant Breast Cancer Brain Metastases." Clinical Cancer Research, vol. 25, no. 11, 2019, https://doi.org/10.1158/1078-0432.CCR-18-3049.

Warning: These citations may not always be 100% accurate.